Irhythm (IRTC) traded flat 0 % during a 24 hours period ending at 10:57 PM Central Europe on Monday 26th. One Irhythm stock can currently be bought for about USD 121.93 on popular exchanges. Current supply of Irhythm stocks is 33 mn. Irhythm has a current market capitalization of USD 4 bn and approximately USD 55.4 mn worth of Irhythm was traded on exchanges in the last 24 hours. Since last month end, Irhythm has traded 9.45 % up. Simple moving average of last 200 days is at USD 115.44. The highest price of past 52 weeks was recorded at USD 212 on 10/31/2025. 52 weeks low was at USD 100.7 on 10/08/2026.
Here is how related stocks have performed in the past 24 hours:
Acushnet (GOLF) traded down -0.81 % and now trades at USD 81.77. Acushnet has a market capitalisation of USD 4.8 bn. Current price/earnings ratio for Acushnet is 22.3.
Iridium Communications (IRDM) traded up 1.39 % and now trades at USD 44.52. Current market capitalisation for Iridium Communications is USD 4.7 bn. Current price/earnings ratio for Iridium Communications is 29.1. Iridium Communications continues to face heightened scrutiny amid growing concerns over satellite‑based maritime communications. Recent reports highlight increased GPS interference and jamming in the Gulf of Hormuz, which has pressured operators such as Viasat and Iridium to assess network resilience. The company’s global low‑Earth‑orbit constellation, designed to deliver worldwide connectivity, is now being evaluated under scenarios of congested and degraded links. Analysts note that while Iridium’s infrastructure offers extensive coverage, the practical performance of its services during periods of signal disruption remains uncertain. The company has not provided new guidance on its commercial outlook, but observers are monitoring how evolving interference patterns and competition from emerging software‑centric solutions might shape future demand for its satellite links.
Lumen (LUMN) traded up 2.47 % and now trades at USD 4.43. Current market capitalisation for Lumen is USD 4.7 bn.
Travere Therapeutics (TVTX) traded down -4.48 % and now trades at USD 49.97. Travere Therapeutics has a market capitalisation of USD 4.7 bn.
Definium Therapeutics (DFTX) traded down -0.92 % and now trades at USD 35.68. Current market capitalisation for Definium Therapeutics is USD 4.8 bn.
About Irhythm
iRhythm Technologies, Inc. is a health care equipment and supplies company based in San Francisco, United States. The company specializes in developing, producing, and distributing medical instruments for monitoring cardiac rhythms. IRhythm Technologies offers palpation, shortness of breath, and fatigue monitoring devices for physicians, clinical staff, and patients in the United States. You can find more information about their products and services on their website, www.irhythmtech.com , and they are listed on the Nasdaq stock exchange. Their initial public offering (IPO) date was October 20, 2016.
